Novartis AG
NYSE:NVS
Novartis AG
NYSE:NVS
Price:
146.03
USD
-1.46%
Market Closed
Market Cap:
$295.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Novartis AG
NYSE:NVS
|
CH |
|
Accelerant Holdings
NYSE:ARX
|
KY |
|
S
|
SP Systems Co Ltd
KOSDAQ:317830
|
KR |
|
I
|
Interlink Telecom PCL
SET:ITEL
|
TH |
|
J
|
Jiangsu Changqing Agrochemical Co Ltd
SZSE:002391
|
CN |
|
Concentradora Fibra Hotelera Mexicana SA de CV
BMV:FIHO12
|
MX |
|
Microsaic Systems PLC
LSE:MSYS
|
UK |
|
T
|
Test Rite International Co Ltd
TWSE:2908
|
TW |
|
W
|
Wellard Ltd
ASX:WLD
|
AU |
|
Shenzhen Fluence Technology PLC
SZSE:300647
|
CN |
|
Old Republic International Corp
NYSE:ORI
|
US |
|
Sichuan Etrol Technologies Co Ltd
SZSE:300370
|
CN |
|
G
|
Green Impact Partners Inc
XBER:04B
|
CA |
|
H
|
Hunan New Wellful Co Ltd
SSE:600975
|
CN |
|
I
|
II-VI Inc
LSE:0LHO
|
US |
|
E
|
EuBiologics Co Ltd
KOSDAQ:206650
|
KR |
|
N
|
Nanjing Toua Hardware&Tools Co Ltd
SZSE:301125
|
CN |
|
vTv Therapeutics Inc
NASDAQ:VTVT
|
US |
|
China Communications Construction Co Ltd
SSE:601800
|
CN |
|
G
|
Gapwaves AB
STO:GAPW B
|
SE |
Relative Value
The Relative Value of one
NVS
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 146.03 USD,
Novartis AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NVS Relative Value
HIDDEN
Multiples Across Competitors
NVS Competitors Multiples
Novartis AG Competitors
Novartis AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
Novartis AG
NYSE:NVS
|
221.8B USD | 5.1 | 20.6 | 12.8 | 16.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 | |
| FR |
|
Sanofi SA
PAR:SAN
|
94B EUR | 2 | 12 | 10.1 | 10.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
